Literature DB >> 21931994

HPV typing and its relation with apoptosis in cervical carcinoma from Indian population.

M Shabbir Alam1, Asgar Ali, Syed Jafar Mehdi, Nisreen Sherif Alyasiri, Zakia Kazim, Swaraj Batra, A K Mandal, M Moshahid Alam Rizvi.   

Abstract

Definite progress in understanding the etiology of cervical cancer has been achieved, and some types of human papillomavirus have been established as the central cause of cervical cancer worldwide. This study investigates the human papillomavirus infection and its correlation with apoptosis and clinicopathologic characteristics in squamous cell carcinoma of uterine cervix. Human papillomavirus typing was done by type-specific primers for high-risk human papillomavirus using standard polymerase chain reaction method. Programmed cell death (apoptosis) was determined by terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling assay. Human papillomavirus infection in tissue biopsy of cervical carcinoma was detected in 131 of 135 (97%) cases. Among the positive cases of human papillomavirus, 123 (94%) cases were human papillomavirus type 16, and five (4%) cases were human papillomavirus type 18. Out of 135 cervical carcinoma cases, 81 (60%) cases showed presence of apoptosis. The phenomenon of apoptosis was seen slightly higher in squamous cell carcinoma than in adenocarcinoma (40% in squamous cell carcinoma and 33% in adenocarcinoma). The human papillomavirus infection in cervical cancer might not play any role in the occurrence of apoptosis.

Entities:  

Mesh:

Year:  2011        PMID: 21931994     DOI: 10.1007/s13277-011-0233-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Human papillomaviruses.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1995

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 3.  Persistent human papillomavirus infection and cervical neoplasia.

Authors:  Alex Ferenczy; Eduardo Franco
Journal:  Lancet Oncol       Date:  2002-01       Impact factor: 41.316

4.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Human papillomavirus 18 oncoproteins E6 and E7 enhance irradiation- and chemotherapeutic agent-induced apoptosis in p53 and Rb mutated cervical cancer cell lines.

Authors:  G Kilic; M Cardillo; M Ozdemirli; B Arun
Journal:  Eur J Gynaecol Oncol       Date:  1999       Impact factor: 0.196

7.  Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells.

Authors:  Jung-Min Oh; Su-Hyeong Kim; Eun-Ah Cho; Yong-Sang Song; Woo-Ho Kim; Yong-Sung Juhnn
Journal:  Carcinogenesis       Date:  2009-12-16       Impact factor: 4.944

8.  Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells.

Authors:  Theresia Karl; Nadine Seibert; Michael Stöhr; Hans Osswald; Frank Rösl; Patrick Finzer
Journal:  Cancer Lett       Date:  2006-02-20       Impact factor: 8.679

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

Review 10.  The molecular genetics of cervical carcinoma.

Authors:  P A Lazo
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

View more
  6 in total

1.  The prognosis significance of TGF-β1 and ER protein in cervical adenocarcinoma patients with stage Ib~IIa.

Authors:  Dong-Mei Fan; Xiao-Yu Tian; Rui-Fang Wang; Juan-Juan Yu
Journal:  Tumour Biol       Date:  2014-08-12

2.  Implication of androgen receptor in urinary bladder cancer: a critical mini review.

Authors:  Arshad H Rahmani; Mohammad Alzohairy; Ali Yousif Y Babiker; Amjad A Khan; Salah M Aly; Moshahid A Rizvi
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

3.  Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-κB pathway.

Authors:  Jingwei Zhang; Yunyan Zhang; Shuang Liu; Qingmeng Zhang; Yan Wang; Liping Tong; Xiaohang Chen; Yuting Ji; Qinglong Shang; Baozhan Xu; Ming Chu; Lanlan Wei
Journal:  Tumour Biol       Date:  2013-04-18

4.  Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.

Authors:  Rehana Qureshi; Himanshu Arora; Shilpi Biswas; Ahmad Perwez; Afreen Naseem; Saima Wajid; Gauri Gandhi; Moshahid Alam Rizvi
Journal:  Tumour Biol       Date:  2016-01-14

Review 5.  Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.

Authors:  Arshad H Rahmani; Mohammad A Alzohairy; Masood A Khan; Salah M Aly
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-18       Impact factor: 2.629

6.  Human papillomavirus oncoproteins and apoptosis (Review).

Authors:  Peiyue Jiang; Ying Yue
Journal:  Exp Ther Med       Date:  2013-10-30       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.